Roquefort Therapeutics (ROQ) Stock Chart & Stock Price History GBX 3.92 +0.02 (+0.59%) (As of 12/20/2024 11:17 AM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsInsider Trades Roquefort Therapeutics Stock Price Performance 5 Day Performance-9.82%1 Month Performance-4.78%3 Month Performance+8.97%6 Month Performance-10.84%Year-To-Date Performance-45.89%1 Year Performance-45.89% Receive ROQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address How to piss off your liberal friends… and profit from it (Ad)Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now ROQ Stock Chart for Sunday, December, 22, 2024 ROQ Chart by TradingView Roquefort Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024GBX 3.82GBX 3.92+2.59%GBX 4.08GBX 3.80520,577 shs£5.07 million12/19/2024GBX 3.81GBX 3.82+0.37%GBX 4GBX 3.721.28 million shs£4.94 million12/18/2024GBX 4.35GBX 3.81-12.41%GBX 4.20GBX 3.801.42 million shs£4.92 million12/17/2024GBX 4.50GBX 4.35-3.33%GBX 4.55GBX 4.10761,441 shs£5.62 million12/16/2024GBX 4.50GBX 4.50GBX 4.68GBX 4.33866,614 shs£5.81 million12/13/2024GBX 4.90GBX 4.50-8.16%GBX 4.90GBX 4.301.51 million shs£5.81 million Get the Latest News and Ratings for ROQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024GBX 4.30GBX 4.90+13.95%GBX 4.90GBX 4.231.79 million shs£6.33 million12/11/2024GBX 4.08GBX 4.30+5.39%GBX 4.30GBX 3.851.10 million shs£5.55 million12/10/2024GBX 4.11GBX 4.08-0.68%GBX 4.30GBX 3.701.36 million shs£5.27 million12/09/2024GBX 3.90GBX 4.11+5.33%GBX 4.20GBX 3.851.39 million shs£5.31 million12/06/2024GBX 4.15GBX 3.98-4.10%GBX 4.18GBX 3.83599,117 shs£5.14 million12/05/2024GBX 4.50GBX 4.15-7.78%GBX 4.35GBX 4.03965,052 shs£5.36 million12/04/2024GBX 4.50GBX 4.50GBX 4.50GBX 4.231.06 million shs£5.81 million12/03/2024GBX 4.80GBX 4.50-6.25%GBX 4.80GBX 4.291.45 million shs£5.81 million12/02/2024GBX 4.35GBX 4.80+10.34%GBX 5.05GBX 4.027.64 million shs£6.20 million11/29/2024GBX 4.20GBX 4.35+3.57%GBX 4.40GBX 4950,202 shs£5.62 million11/28/2024GBX 4.20GBX 4.20GBX 4.40GBX 4.05576,333 shs£5.42 million11/27/2024GBX 4.30GBX 4.20-2.33%GBX 4.50GBX 4.08643,956 shs£5.42 million11/26/2024GBX 3.80GBX 4.30+13.16%GBX 4.50GBX 4.302.28 million shs£5.55 million11/25/2024GBX 4.12GBX 3.80-7.77%GBX 4.50GBX 3.803.43 million shs£4.91 million11/22/2024GBX 3.82GBX 4.12+7.99%GBX 4.38GBX 3.811.29 million shs£5.32 million11/21/2024GBX 4GBX 3.82-4.63%GBX 4.20GBX 3.792.70 million shs£4.93 million Related Companies OPTI Stock Price Chart OBI Stock Price Chart NSCI Stock Price Chart ONC Stock Price Chart SNG Stock Price Chart BVX Stock Price Chart APTA Stock Price Chart CIZ Stock Price Chart FAB Stock Price Chart IXI Stock Price Chart Receive ROQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:ROQ) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThis is the worst sign for the U.S. stock market in 50 yearsThe Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts no...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roquefort Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Roquefort Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ROQ Stock Alerts